Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Lee

Showing results (551-560 of 594) with videos related to

Pageof 60
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung CancerAlejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Journal for Immunotherapy of Cancer|June 30, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohortSandip Pravin Patel, Jillian Fisher, Young Kwang Chae, et al.
Cell|June 22, 2026
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistanceGuang Lei, Zhengze Lu, Zhihao Xu, et al.
Cancer Discovery|April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockadeXianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
Cancers|December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung CancerHui Li, Lingzhi Hong, Pedro Rocha, et al.
Gut|July 10, 2020
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosaLaura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, et al.
JTO Clinical and Research Reports|February 15, 2024
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From <i>EGFR</i>-Mutant NSCLC Informs Potential Therapeutic TargetsBingnan Zhang, Whitney Lewis, C Allison Stewart, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROREmily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine CarcinomaMinglei Zhuo, Yanfang Guan, Xue Yang, et al.
Pageof 60

Showing results (551-560 of 594) with videos related to

Sort By:
Pageof 60
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung CancerAlejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Journal for Immunotherapy of Cancer|June 30, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohortSandip Pravin Patel, Jillian Fisher, Young Kwang Chae, et al.
Cell|June 22, 2026
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistanceGuang Lei, Zhengze Lu, Zhihao Xu, et al.
Cancer Discovery|April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockadeXianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
Cancers|December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung CancerHui Li, Lingzhi Hong, Pedro Rocha, et al.
Gut|July 10, 2020
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosaLaura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, et al.
JTO Clinical and Research Reports|February 15, 2024
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From <i>EGFR</i>-Mutant NSCLC Informs Potential Therapeutic TargetsBingnan Zhang, Whitney Lewis, C Allison Stewart, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROREmily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine CarcinomaMinglei Zhuo, Yanfang Guan, Xue Yang, et al.
Pageof 60